Topics

FDA will allow doctors to use convalescent plasma to treat critical COVID-19 patients

07:26 EDT 26 Mar 2020 | Pharmafile

The FDA have announced they will allow doctors to use convalescent plasma, collected from people who recovered from COVID-19, to treat those who are in critical condition from the virus.

Although there is not much evidence that this is an effective treatment, the FDA believe that because this plasma contains antibodies against the virus it could help patients suffering from the disease. The use of convalescent plasma has been studied and utilized in other pandemics like the H1N1 flu pandemic, and also to treat other coronavirus epidemics like SARS and MERS.

Image caption: 
Photo by FDA

read more

Original Article: FDA will allow doctors to use convalescent plasma to treat critical COVID-19 patients

NEXT ARTICLE

More From BioPortfolio on "FDA will allow doctors to use convalescent plasma to treat critical COVID-19 patients"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...